Glycos to report on bio-isoprene progress

ERJ staff report (DS)

Washington DC -- Glycos Biotechnologies, Inc. (GlycosBio) will discuss the company's expansion plans into Malaysia including its focus on the development of isoprene, at the BIO International Convention taking place June 27th - 30th in Washington, DC.

GlycosBio is continuing to move forward with its expansion plans into Asia and will make a formal announcement on the selection of a lead EPC contractor in August of 2011 for its biochemical plant and biotechnology research and development facility to be located at Bio-XCell, a dedicated biotechnology park in Johor, Malaysia. Construction of the commercial plant will begin shortly thereafter with completion expected in Q4 of 2012.

“Isoprene is a key building block molecule used in the production of synthetic rubber and block co-polymer products,” said Cilento. “GlycosBio is well positioned to support the Malaysian rubber industry as well the emerging regional synthetic rubber market as isoprene has a global demand of approximately 850,000 metric tons per year," said Richard C. Cilento Jr., Chief Executive Officer

This is an external link and should open in a new window. If the window does not appear, please check your pop-up blocking software. ERJ is not responsible for the content of external sites.

Press release from GlycosBio